"also, the company is in a position where we need to cap raise probably mid year" - per the media article I shared in the Media thread the company has said they are funded until 2026 what with the recent placement not fully deposited into the bank's coffers which is on top of the oppies being exercised.
I have a feeling that still buying the oppies at current price and then converting or buying the heads themselves - both of them till mid-March, could prove to be great buying in hindsight once April results are out, or even without it.
Just imagine the prophylactic arm itself has been derisked and we only phase 3 in it before FDA approval gate. How could the company be valued at $25Mn MC with the potential for the US army to load up on the millions of doses if approved by FDA? That could exceed the annual sales volume in the future with just the US DoD as one customer!
DYOR.
ILA Price at posting:
13.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)